Fundraising FoxAvivomed
Roseville, US · Founded 2021 · Delaware corporation · 3 known investors
Find your way into Avivomed
Sign up to see every warm intro you have to Avivomed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avivomed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
Founders & leadership
Avivomed was founded in 2021 by Lynn Elliott and Mudit Jain.
LE
Lynn ElliottCo-Founder
MJ
Mudit JainCo-Founder
PM
Paul MazanecChief Executive OfficerPaul Mazanec is an engineer with experience in product development and technical leadership at companies designing active implantable medical devices and consumer electronics. He is CEO of Avivomed, which develops minimally invasive neuromodulation therapies for obstructive sleep apnea.
SM
Stephen MassonNamed on SEC filing
Board
TC
Theresa C. PappasBoard director
KP
CD
Casper de ClercqBoard director
DR
Investors · 3
Hatteras Venture Partners✓ confirmed by AvivomedResearch Triangle · $500K – $4M
How we know: the company's own site · funding news · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$25.1M disclosed across 2 rounds · 2021–2026
▶$5MraisedApr 2026 · 7 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul MazanecExecutive Officer, Director
- Theresa C. PappasDirector
- Ketan PatelDirector
- Casper de ClercqDirector
- Douglas ReedDirector
- Mudit K. JainDirector
- Offering amount
- $12M
- Amount sold
- $5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$20.1MraisedNov 2021 · 6 investors · BiotechnologyRule 506(b)
▶$20.1MraisedNov 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ketan PatelDirector
- Mudit K. JainDirector
- Stephen MassonExecutive Officer, Director
- Casper de ClercqDirector
- Theresa C. PappasDirector
- Douglas ReedDirector
- Offering amount
- $32M
- Amount sold
- $20.1M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
AVIAAVIA operates a network and advisory platform for health systems, providing benchmarking, market intelligence, and peer collaboration to support their digital transformation and AI adoption. It serves hospitals and health systems and includes offerings like AVIA Marketplace and Panda Health for evaluating digital health companies.
IveacareIVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.
NuvoMedNuvomed is a family-operated company that develops and distributes affordable health and wellness devices, with a focus on hearing enhancement, physical therapy, and mental wellness. It sells holistically therapeutic products to consumers across the United States, originally supplying small pharmacies.
Iriva MedicaliRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases. A NuXcel spinoff based in Minneapolis, it develops implantable neuromodulation therapies targeting large patient populations with unmet clinical needs.
Avvio MedicalAvvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa. It is the regional arm of Avvio Medical, whose investigational medical device has not yet received regulatory clearance.
Companies working in the same space as Avivomed.
Frequently asked questions
- What does Avivomed do?
- Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
- Who founded Avivomed?
- Avivomed was founded by Lynn Elliott, Mudit Jain in 2021.
- Who are Avivomed's investors?
- Avivomed's investors include Hatteras Venture Partners, Treo Ventures, Llc, F-Prime Capital.
- How much funding has Avivomed raised?
- Avivomed has disclosed $25.1M raised across 2 rounds.
- Where is Avivomed headquartered?
- Avivomed is headquartered in Roseville, US.